In June 2022, Enanta filed a lawsuit against Pfizer in a US district court in Massachusetts, claiming that the big pharma ...

Enanta Pharmaceuticals (NASDAQ:ENTA) announced on Wednesday a lawsuit filed in the EU against Pfizer (NYSE:PFE) and some of ...

Enanta Pharmaceuticals ( ($ENTA) ) has shared an announcement. On August 20, 2025, Enanta Pharmaceuticals announced it filed a patent infringement ...

Enata Pharmaceuticals is suing Pfizer in a European Union court, alleging Pfizer's Paxlovid Covid-19 antiviral violates one of its patents. Enata said its patent, published Wednesday in the European ...

The patent in question, U.S. Patent No. 11,358,953, was claimed by Enanta to be infringed by Pfizer through the manufacture, use, and sale of Paxlovid.

The court allows Pfizer's motion for summary judgment as to invalidity and denies Enanta's motion for summary judgment as to infringement. The court denies the parties' respective motions to exclude ...

Enanta plans to issue its full year and fiscal fourth quarter financial results press release on November 25, 2024. About Enanta Pharmaceuticals, Inc.

Enanta Pharmaceuticals' shares experienced a downturn on Wednesday, which was attributed to Pfizer's announcement. Sisunatovir, which Pfizer acquired through the purchase of ReViral, was anticipated ...

Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) Q2 2024 Earnings Conference Call May 6, 2024 4:30 PM ET Company Participants Jennifer Viera - Investor Relations Jay Luly - President and Chief ...

Company News Published12/24/2024, 07:05 AM Pfizer prevails in Enanta patent case over Covid-19 drug View all comments (0)0 ENTA -2.56% ...